Phase 1-2 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
ImmunoVaccine Technologies, Inc.
ClinicalTrials.gov Identifier:
NCT01416038
First received: August 9, 2011
Last updated: December 14, 2015
Last verified: December 2015